Journal for ImmunoTherapy of Cancer (Nov 2021)

774 An induced pluripotent stem cell (iPSC) vaccine is highly immunogenic and reduces lung metastases in a mouse model of melanoma

Matthias Hundt,
Peter Bove,
Ivan Hernandez,
Michelle Li,
Lucia Beviglia,
Pratima Kundu,
Babacar Ndoye,
Nigel Kooreman,
Stephen Wolpe,
Lynne Bui

Affiliations

Matthias Hundt: Khloris Biosciences, Mountain View, CA, United States
Peter Bove: Khloris Biosciences, Mountain View, CA, United States
Ivan Hernandez: Khloris Biosciences, Mountain View, CA, United States
Michelle Li: Khloris Biosciences, Mountain View, CA, United States
Lucia Beviglia: Khloris Biosciences, Mountain View, CA, United States
Pratima Kundu: Khloris Biosciences, Mountain View, CA, United States
Babacar Ndoye: Khloris Biosciences, Mountain View, CA, United States
Nigel Kooreman: Khloris Biosciences, Mountain View, CA, United States
Stephen Wolpe: Khloris Biosciences, Mountain View, CA, United States
Lynne Bui: Khloris Biosciences, Mountain View, CA, United States

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.774
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal